相关实验视频

Updated: Jun 4, 2025

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

自主血液在眼睛表面疾病的管理

Ayuba Suleman¹, Gladness Aluyi-Osa¹, Folorunsho Ashipa²

¹Department of Ophthalmology, Africa Eye Laser Centre, Km 7, Benin 300105, Nigeria.

World journal of experimental medicine

|December 23, 2024

概括

富含生长因子的自身血液疗法对治疗干眼病等眼睛表面疾病有很大的前景. 虽然有效,但需要进一步的研究来优化其使用和解决挑战.

科学领域:

眼科医生眼科眼科
再生医学是一种再生医学.

背景情况:

眼表面疾病会破坏视力,并可能导致病理状况.
眼睛表面包括角膜,结膜和膜,对于视觉功能至关重要.

研究的目的:

为眼睛表面疾病提供自主血液治疗的综合审查.
讨论它的生理基础,临床应用,技术,挑战和未来的方向.

主要方法:

在眼科中对自身血液治疗的当前研究的文献综述.
临床研究,作用机制和治疗方案的分析.
与传统的治疗方法比较,比如眼滴.

主要成果:

自主血疗法在促进角膜愈合,减少炎症和改善膜稳定性方面表现出有效性.
临床研究支持其用于诸如持续的上皮缺陷,神经缩性角质病以及干眼疾病等疾病.
治疗中丰富的生长因子和细胞因子成分有助于其治疗潜力.

结论:

自主血疗法是眼睛表面疾病的有前途的辅助治疗方法.
挑战包括治疗变异性,不良反应和患者选择,需要进一步调查.
完善协议和探索协同方法可以提高患者的治疗结果和生活质量.

关键词:

自生血液自生血液.细胞因子 (cytokines) 是一种细胞因子.眼睛干燥眼睛干燥眼皮表面疾病眼皮表面疾病眼片,是一部催片.

更多相关视频

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Published on: March 24, 2023

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...